Literature DB >> 2680507

Pathophysiological mechanisms of ventricular tachyarrhythmias.

G Breithardt1, M Borggrefe, A Martinez-Rubio, T Budde.   

Abstract

The pathophysiological background for ventricular tachyarrhythmias based on experimental and clinical evidence is presented. Sudden cardiac death may occur as the first manifestation of coronary artery disease without antecedent complaints or it may occur in patients with a previous myocardial infarction. In the latter situation, a circumscribed area of cardiac tissue may be responsible for the genesis and maintenance of a ventricular tachyarrhythmia which may be called the 'arrhythmogenic substrate'. This zone of electrically abnormal ventricular myocardium is usually located at the border of a previous myocardial infarction, and is characterized by islands of relatively viable muscle alternating with areas of necrosis and, later, fibrosis. The consequent fragmentation of the propagating electromotive forces leads to the development of high-frequency components that can be recorded directly or non-invasively using signal-averaging techniques. These signals have been called ventricular late potentials. The 'arrhythmogenic substrate' may be present permanently or may rise acutely and be present only transiently in the case of extensive ischaemia or acute myocardial infarction. In the setting of a chronic 'arrhythmogenic substrate', this electrically abnormal tissue may be triggered by spontaneously occurring ventricular ectopic beats or salvoes or by programmed ventricular stimulation, as well as by transient episodes of ischaemic causing spontaneous arrhythmias. These trigger factors modify the 'arrhythmogenic substrate' in such a way that ventricular tachyarrhythmias are sustained. It is apparent that sudden cardiac death is due to a wide spectrum of pathophysiological mechanisms which may be interrelated. There is obviously no single parameter that helps the clinician to predict the propensity for sudden cardiac death in the individual patient.

Entities:  

Mesh:

Year:  1989        PMID: 2680507     DOI: 10.1093/eurheartj/10.suppl_e.9

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Late potentials as predictors of risk after thrombolytic treatment?

Authors:  G Breithardt; M Borggrefe; U Karbenn
Journal:  Br Heart J       Date:  1990-09

Review 2.  Adhesion proteins, stem cells, and arrhythmogenesis.

Authors:  Nikki Gillum; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2008-01-05       Impact factor: 3.231

3.  Iron-Sensitive Cardiac Magnetic Resonance Imaging for Prediction of Ventricular Arrhythmia Risk in Patients With Chronic Myocardial Infarction: Early Evidence.

Authors:  Ivan Cokic; Avinash Kali; Hsin-Jung Yang; Raymond Yee; Richard Tang; Mourad Tighiouart; Xunzhang Wang; Warren S Jackman; Sumeet S Chugh; James A White; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

4.  Cardiac vulnerability assessment from electrical microvariability of high-resolution electrocardiogram.

Authors:  H A Kestler; J Wöhrle; M Höher
Journal:  Med Biol Eng Comput       Date:  2000-01       Impact factor: 3.079

5.  Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.

Authors:  Hua-Dong Yu; Shuang Xia; Cheng-Qin Zha; Song-Bai Deng; Jian-Lin Du; Qiang She
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

6.  Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes.

Authors:  L W van Laake; E G van Donselaar; J Monshouwer-Kloots; C Schreurs; R Passier; B M Humbel; P A Doevendans; A Sonnenberg; A J Verkleij; Christine L Mummery
Journal:  Cell Mol Life Sci       Date:  2009-10-22       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.